Diseases	diseases	O	O	OTHERS	I
of	of	O	O	OTHERS	I
peripheral	peripheral	O	O	OTHERS	I
nerves	nerves	O	O	OTHERS	I
as	as	O	O	O	O
seen	seen	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
Nigerian	nigerian	O	O	O	O
African	african	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
anatomical	anatomical	O	O	O	O
and	and	O	O	O	O
aetiological	aetiological	O	O	O	O
diagnoses	diagnoses	O	O	O	O
of	of	O	O	O	O
peripheral	peripheral	O	O	OTHERS	I
nerve	nerve	O	O	OTHERS	I
disease	disease	O	O	OTHERS	I
excluding	excluding	O	O	O	O
its	its	O	O	O	O
primary	primary	O	O	O	O
benign	benign	O	O	O	O
and	and	O	O	O	O
malignant	malignant	O	O	O	O
disorders	disorders	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
seen	seen	O	O	O	O
in	in	O	O	O	O
358	358	O	O	O	O
Nigerians	nigerians	O	O	O	O
are	are	O	O	O	O
presented	presented	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
male	male	O	O	O	O
preponderance	preponderance	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
peak	peak	O	O	O	O
incidence	incidence	O	O	O	O
is	is	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
fourth	fourth	O	O	O	O
decade	decade	O	O	O	O
.	.	O	O	O	O

Sensori-motor	sensori-motor	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
was	was	O	O	O	O
the	the	O	O	O	O
commonest	commonest	O	O	O	O
presentation	presentation	O	O	O	O
(	(	O	O	O	O
50	50	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Guillain-Barr	guillain-barr	O	O	O	O
  	  	O	O	O	O
syndrome	syndrome	O	O	O	O
was	was	O	O	O	O
the	the	O	O	O	O
commonest	commonest	O	O	O	O
identifiable	identifiable	O	O	O	O
cause	cause	O	O	O	O
(	(	O	O	O	O
15.6	15.6	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
accounting	accounting	O	O	O	O
for	for	O	O	O	O
half	half	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
cases	cases	O	O	O	O
with	with	O	O	O	O
motor	motor	O	O	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Peripheral	peripheral	O	DISEASE	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
nutritional	nutritional	O	O	OTHERS	I
deficiency	deficiency	O	O	OTHERS	I
of	of	O	O	O	O
thiamine	thiamine	O	O	OTHERS	I
and	and	O	O	O	O
riboflavin	riboflavin	O	O	OTHERS	I
was	was	O	O	O	O
common	common	O	O	O	O
(	(	O	O	O	O
10.1	10.1	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
presented	presented	O	O	O	O
mainly	mainly	O	O	O	O
as	as	O	O	O	O
sensory	sensory	O	O	O	O
and	and	O	O	O	O
sensori-motor	sensori-motor	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Diabetes	diabetes	O	DISEASE	OTHERS	I
mellitus	mellitus	O	DISEASE	OTHERS	I
was	was	O	O	O	O
the	the	O	O	O	O
major	major	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
autonomic	autonomic	O	DISEASE	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Isoniazid	isoniazid	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
frequent	frequent	O	O	O	O
agent	agent	O	O	O	O
in	in	O	O	O	O
drug-induced	drug-induced	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Migraine	migraine	O	DISEASE	OTHERS	I
(	(	O	O	O	O
20	20	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
not	not	O	O	O	O
an	an	O	O	O	O
uncommon	uncommon	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
cranial	cranial	O	O	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
although	although	O	O	O	O
malignancies	malignancies	O	DISEASE	OTHERS	I
arising	arising	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
reticuloendothelial	reticuloendothelial	O	O	O	O
system	system	O	O	O	O
or	or	O	O	O	O
related	related	O	O	O	O
structures	structures	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
head	head	O	O	O	O
and	and	O	O	O	O
neck	neck	O	O	O	O
were	were	O	O	O	O
more	more	O	O	O	O
frequent	frequent	O	O	O	O
(	(	O	O	O	O
26	26	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
26.5	26.5	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
all	all	O	O	O	O
the	the	O	O	O	O
cases	cases	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
aetiology	aetiology	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
was	was	O	O	O	O
undetermined	undetermined	O	O	O	O
.	.	O	O	O	O

Heredofamilial	heredofamilial	O	O	O	O
and	and	O	O	O	O
connective	connective	O	O	OTHERS	I
tissue	tissue	O	O	OTHERS	I
disorders	disorders	O	O	OTHERS	I
were	were	O	O	O	O
rare	rare	O	O	O	O
.	.	O	O	O	O

Some	some	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
factors	factors	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
clinical	clinical	O	O	O	O
presentation	presentation	O	O	O	O
and	and	O	O	O	O
pathogenesis	pathogenesis	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
neuropathies	neuropathies	O	O	OTHERS	I
are	are	O	O	O	O
briefly	briefly	O	O	O	O
discussed	discussed	O	O	O	O
.	.	O	O	O	O

